Carney complex
Carney complex is a multisystem genetic condition characterised by endocrine dysfunction, cardiac myxoma and pigmentation.
Overview
Carney complex is a multisystem condition caused by constitutional (germline) pathogenic variants in the PRKAR1A gene. Classically, it manifests as skin pigmentation, endocrine dysfunction and cardiac myxoma.
Clinical features
A diagnosis of Carney complex can be established in a patient with two or more major diagnostic criteria and/or by identification of a heterozygous constitutional (germline) pathogenic variant.
Endocrinological features, with the major diagnostic criteria marked in bold, include:
- acromegaly (somatotroph hyperplasia and/or adenoma):
- tall stature (rare);
- acral enlargement; and
- corticotrophima (very rare);
- primary pigmented adrenal hyperplasia:
- Cushing syndrome;
- thyroid carcinoma or multiple hypoechoic nodules on thyroid ultrasound in a patient under 18 years of age;
- gonadal lesions:
- large-cell calcifying sertoli cell tumour;
- leydig cell tumour (rare):
- premature or accelerated puberty in boys; and
- ovarian cystadenoma.
Dermatological features, with the major diagnostic criteria marked in bold, include:
- spotty skin pigmentation with typical distribution (lips, conjunctiva and inner or outer canthi, vaginal and penile mucosa);
- lentigines;
- myxoma; and
- epithelioid-type blue naevus.
Cardiac features, with the major diagnostic criteria marked in bold, include:
- cardiac myxoma:
- collapse;
- congestive cardiac failure; and
- embolic phenomena.
Breast features, with the major diagnostic criteria marked in bold, include:
- myxomatosis; and
- ductal adenoma.
Other major diagnostic criteria include:
- osteochondrotic myxoma; and
- melanotic schwannoma.
Clinical features possibly associated with Carney complex but not considered diagnostic include:
- intense freckling (without darkly pigmented spots or typical distribution);
- common-type blue naevus;
- café-au-lait macules or other birthmarks;
- elevated insulin-like growth factor 1 (IGF-1) levels and non-suppressed growth hormone levels on oral glucose tolerance test in the absence of overt clinical features of acromegaly;
- cardiomyopathy;
- pilonidal sinus;
- history of Cushing syndrome, acromegaly or sudden death in extended family;
- multiple skin tags or other skin lesions;
- lipomas;
- colonic polyps (usually in association with acromegaly);
- hyperprolactinaemia (usually mild and almost always combined with clinical or subclinical acromegaly);
- single, benign thyroid nodule in a child younger than 18 years of age;
- multiple thyroid nodules in an individual older than 18 years of age (detected on ultrasound examination); and
- family history of carcinoma, in particular of the thyroid, colon, pancreas and ovary, as well as other multiple benign or malignant tumours.
Genetics
Carney complex is most commonly (70%–80% of cases) caused by constitutional (germline) pathogenic variants in the PRKAR1A gene.
Some cases show linkage to a region on chromosome 2p16, but the gene responsible in these cases is unknown. Single gene testing of PRKAR1A (code R156.1) is available. If test results are negative, discussion with a multidisciplinary team is recommended to consider somatic testing for mosaicism or further testing depending on clinical phenotype. Large deletions in PRKAR1A are associated with a more severe phenotype.
For more information about genomic testing, see Presentation: Patient with Carney complex.
Inheritance and genomic counselling
Carney complex is an autosomal dominant condition with almost complete penetrance. Around 30% of cases may occur as a consequence of a de novo pathogenic variant. A parent with a pathogenic variant has a 50% chance of passing the variant on to their child. Rare cases of gonadal mosaicism in a parent could result in affected children with unaffected parents.
Management
Management of patients with Carney complex is intricate due to its rarity and multisystem manifestations. Care should be delivered via a multidisciplinary team, which may include (but is not limited to) adult and/or paediatric endocrinologists, cardiologists, cardiac surgeons, endocrine surgeons, oncologists, dermatologists and specialist nurses.
Resources
For clinicians
- Genomics England: Genomic Medicine Service (GMS) Signed Off Panels Resource
- NHS England: National Genomic Test Directory
References:
- Bouys L and Bertherat J. ‘Management of endocrine disease: Carney complex: Clinical and genetic update 20 years after the identification of the CNC1 (PRKAR1A) gene’. European Journal of Endocrinology 2021: volume 184, issue 3, pages R99–R109. DOI: 10.1530/EJE-20-1120
For patients
- Association for Multiple Endocrine Neoplasia Disorders (AMEND)
- National Organization for Rare Disorders: Carney complex
- The Pituitary Foundation